Iqvia Holdings Inc.
Iqvia Holdings
IQV · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $16.3B
- Assets
- $29.9B
- SEC filing
- DEF 14A
- Filed
- February 27, 2026
Executive Compensation
Compensation reported for Iqvia Holdings’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Ari Bousbib
Chairman And Chief Executive Officer
$28.1M
Reported total
- Salary
- $1,800,000
- Stock awards
- $15,749,957
- Incentives
- $4,966,127
- Option awards
- $4,528,317
- Other
- $1,083,844
Ronald E. Bruehlman
Executive Vice President, Chief Financial Officer W. Richard Staub, Iiipresident, Research & Development Solutions
$11.4M
Reported total
- Salary
- $905,000
- Stock awards
- $6,749,807
- Incentives
- $1,294,584
- Option awards
- $2,249,984
- Other
- $244,825
Alistair R. Grenfell
President, Commercial Solutions
$9.7M
Reported total
- Salary
- $629,907
- Stock awards
- $5,999,964
- Incentives
- $806,945
- Option awards
- $1,999,950
- Other
- $267,740
Eric M. Sherbet
Executive Vice President, General Counsel And Secretary
$5.5M
Reported total
- Salary
- $665,000
- Stock awards
- $2,999,982
- Incentives
- $764,301
- Option awards
- $999,946
- Other
- $71,569
Ari Bousbib
Chairman And Chief Executive Officer
$28.1M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed February 27, 2026.
- Salary
- $1.8M
- Stock Awards
- $15.7M
- Option Awards
- $4.5M
- Incentives
- $5M
- Other
- $1.1M
Historical Compensation
Ari Bousbib total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,800,000 | $15,749,957 | $28,128,245 |
| 2024 | $1,800,000 | $15,749,918 | $26,732,998 |
| 2023 | $1,800,000 | $16,405,071 | $29,151,752 |
Named Executive Officers
Ari Bousbib
Chairman And Chief Executive Officer
Iqvia Holdings · IQV
$28.1M
FY 2025 · DEF 14A
Ronald E. Bruehlman
Executive Vice President, Chief Financial Officer W. Richard Staub, Iiipresident, Research & Development Solutions
Iqvia Holdings · IQV
$11.4M
FY 2025 · DEF 14A
Alistair R. Grenfell
President, Commercial Solutions
Iqvia Holdings · IQV
$9.7M
FY 2025 · DEF 14A
Eric M. Sherbet
Executive Vice President, General Counsel And Secretary
Iqvia Holdings · IQV
$5.5M
FY 2025 · DEF 14A
Source information
- Company
- Iqvia Holdings Inc.
- Ticker
- IQV · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- February 27, 2026
- SEC accession number
- 0001628280-26-012892
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →